Alina Kulakova Almind, PhD, is a Senior Research Scientist in Biophysics and Formulation in Early Research and Development at…Alina Kulakova Almind, PhD, is a Senior Research Scientist in Biophysics and Formulation in Early Research and Development at Novo Nordisk. She earned her PhD from the Technical University of Denmark, where she specialized in Biophysics, with focus on Small Angle X-ray Scattering (SAXS). After completing two Postdoctoral Fellowships in the same field, she joined Novo Nordisk, where she has been involved in supporting the early pipeline with biophysical characterization of proteins and peptides, utilizing various biophysical methods.
Complementary techniques for biophysical characterization of peptides and protein-based drug products
Webinar
20/11/2024
15:00
In early research and development of peptide and new protein- based drug products, the combination of biophysical and structural properties is used to inform rational design of stable pharmaceutical formulation. In this webinar, we will share how Small angle X-ray scattering (SAXS) complemented with other scattering methods allows detailed investigation of protein and peptide behaviour across various sample conditions, and can be used to inform triaging of lead candidates or to optimise formulation conditions.
Sign in and learn how Novo Nordisk is combining Dynamic Light Scattering (DLS) with Small Angle X-ray Scattering (SAXS) and Size-Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS) to better understand peptide population distribution and study agglomeration.
Who should attend?
Scientists and researchers interested in stability of biopharmaceuticals, such as peptides.
What you will learn:
Learn how to better understand peptide population distributions and agglomeration tendencies Understand how SAXS and SEC-MALS can overcome the limitations of DLS, particularly in studying peptide aggregation and distribution across different populations.